Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Med Virol ; 95(1): e28380, 2023 01.
Article in English | MEDLINE | ID: covidwho-2148396

ABSTRACT

Children are the high-risk group for COVID-19, and in need of vaccination. However, humoral and cellular immune responses of COVID-19 vaccine remain unclear in vaccinated children. To establish the rational immunization strategy of inactivated COVID-19 vaccine for children, the immunogenicity of either one dose or two doses of the vaccine in children was evaluated. A prospective cohort study of 322 children receiving inactivated COVID-19 vaccine was established in China. The baseline was conducted after 28 days of the first dose, and the follow-up was conducted after 28 days of the second dose. The median titers of receptor binding domain (RBD)-IgG, and neutralizing antibody (NAb) against prototype strain and Omicron variant after the second dose increased significantly compared to those after the first dose (first dose: 70.0, [interquartile range, 30.0-151.0] vs. second dose: 1261.0 [636.0-2060.0] for RBD-IgG; 2.5 [2.5-18.6] vs. 252.0 [138.6-462.1] for NAb against prototype strain; 2.5 [2.5-2.5] vs. 15.0 [7.8-26.5] for NAb against Omicron variant, all p < 0.05). The flow cytometry results showed that the first dose elicited SARS-CoV-2 specific cellular immunity, while the second dose strengthened SARS-CoV-2 specific IL-2+ or TNF-α+  monofunctional, IFN-γ+ TNF-α+  bifunctional, and IFN-γ- IL-2+ TNF-α+ multifunctional CD4+ T cell responses (p < 0.05). Moreover, SARS-CoV-2 specific memory T cells were generated after the first vaccination, including the central memory T cells and effector memory T cells. The present findings provide scientific evidence for the vaccination strategy of the inactive vaccines among children against COVID-19 pandemic.


Subject(s)
COVID-19 Vaccines , COVID-19 , Child , Humans , East Asian People , Interleukin-2 , Pandemics , Prospective Studies , Tumor Necrosis Factor-alpha , COVID-19/prevention & control , SARS-CoV-2 , Vaccination , Immunity, Cellular , Antibodies, Neutralizing , Immunoglobulin G , Antibodies, Viral , Immunity, Humoral
2.
Energy Build ; 277: 112582, 2022 Dec 15.
Article in English | MEDLINE | ID: covidwho-2086155

ABSTRACT

During the COVID-19 pandemic, strict stay-at-home orders have been implemented in many Chinese universities in virus-hit regions. While changes in electricity consumption in the residential sector caused by COVID-19 have been thoroughly analysed, there is a lack of insight into the impact of the stay-at-home order on electricity consumption in university dormitory buildings. Based on questionnaire survey results, this study adopted the statistical Kaplan-Meier survival analysis to analyse the energy-use behaviours of university students in dormitories during the COVID-19 pandemic. The electricity load profiles of the dormitory buildings before and during the implementation of the stay-at-home order were generated and compared to quantitatively analyse the influence of COVID-19 pandemic on the energy-use behaviours of university students, and the proposed load forecasting method was validated by comparing the forecasting results with monitoring data on electricity consumption. The results showed that: 1) during the implementation of the stay-at-home order, electricity consumption in the university dormitory buildings increased by 41.05%; 2) due to the increased use of illuminating lamps, laptops, and public direct drinking machines, the daily electricity consumption increased most significantly from 13:00 to 18:00, with an increase rate of 97.15%; and 3) the morning peak shifted backward and the evening peak shifted forward, demonstrating the effect of implementing the stay-at-home order on reshaping load profiles.

3.
AMB Express ; 12(1), 2022.
Article in English | ProQuest Central | ID: covidwho-1837317

ABSTRACT

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread globally, a series of vaccines, antibodies and drugs have been developed to combat coronavirus disease 2019 (COVID-19). High specific antibodies are powerful tool for the development of immunoassay and providing passive immunotherapy against SARS-CoV-2 and expected with large scale production. SARS-CoV-2 S1 protein was expressed in E. coli BL21 and purified by immobilized metal affinity chromatography, as antigen used to immunize hens, the specific IgY antibodies were extracted form egg yolk by PEG-6000 precipitation, and the titer of anti-S1 IgY antibody reached 1:10,000. IgY single chain variable fragment antibody (IgY-scFv) was generated by using phage display technology and the IgY-scFv showed high binding sensitivity and capacity to S1 protein of SARS-CoV-2, and the minimum detectable antigen S1 protein concentration was 6 ng/µL. The docking study showed that the multiple epitopes on the IgY-scFv interacted with multiple residues on SARS-CoV-2 S1 RBD to form hydrogen bonds. This preliminary study suggests that IgY and IgY-scFv are suitable candidates for the development of immunoassay and passive immunotherapy for COVID-19 to humans and animals.

4.
J Clin Lab Anal ; 36(2): e24211, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1589067

ABSTRACT

BACKGROUND: Presently, the global spread of COVID-19 is still going on, with more than 0.6 million new cases confirmed per day (as of November 20, 2021). However, since China entered a post-epidemic phase in mid-March 2020, the daily number of new domestic infections in the Chinese mainland has been maintained at almost zero or single digits, which was attributed to a series of effective measures for COVID-19 prevention and control adopted by the Chinese government. Among these measures, SARS-CoV-2 nucleic acid testing holds key role for the timely confirmation and isolation of the infections to prevent further transmission. METHODS: Referring to the national policy requirements, since April 30, 2020, The Affiliated Hospital of Qingdao University has conducted SARS-CoV-2 nucleic acid testing in its PCR laboratory for patients and social workers, as well as for environmental monitoring and employee screening. As of mid-November 2020, the daily amount of single-tube samples for nucleic acid testing rose above 4,000. RESULTS: In this article, a rapid and highly effective approach for SARS-CoV-2 nucleic acid daily testing is presented, allowing five technicians to complete nucleic acid testing in 6,500 single-tube samples in one day with a high level of quality. Using this approach, since the samples entered the PCR laboratory, all testing results were reported in 2.5-3 h with satisfactory quality control and precise reporting criterion as prerequisites. CONCLUSION: This testing approach provides a referable workflow for other testing institutions and is expected to play an important role in COVID-19 prevention and control.


Subject(s)
COVID-19 , Nucleic Acid Amplification Techniques , SARS-CoV-2 , COVID-19/diagnosis , COVID-19/prevention & control , China , High-Throughput Nucleotide Sequencing , Humans , Nucleic Acid Amplification Techniques/methods , Nucleic Acid Amplification Techniques/standards , Nucleic Acid Amplification Techniques/statistics & numerical data , Quality Control , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Time Factors
5.
Biochim Biophys Acta Proteins Proteom ; 1870(2): 140736, 2022 02 01.
Article in English | MEDLINE | ID: covidwho-1509583

ABSTRACT

We present an integrated analysis of urine and serum proteomics and clinical measurements in asymptomatic, mild/moderate, severe and convalescent cases of COVID-19. We identify the pattern of immune response during COVID-19 infection. The immune response is activated in asymptomatic infection, but is dysregulated in mild and severe COVID-19 patients. Our data suggest that the turning point depends on the function of myeloid cells and neutrophils. In addition, immune defects persist into the recovery stage, until 12 months after diagnosis. Moreover, disorders of cholesterol metabolism span the entire progression of the disease, starting from asymptomatic infection and lasting to recovery. Our data suggest that prolonged dysregulation of the immune response and cholesterol metabolism might be the pivotal causative agent of other potential sequelae. Our study provides a comprehensive understanding of COVID-19 immunopathogenesis, which is instructive for the development of early intervention strategies to ameliorate complex disease sequelae.


Subject(s)
Asymptomatic Infections , COVID-19/immunology , Cholesterol/metabolism , Convalescence , Proteomics , COVID-19/blood , COVID-19/urine , Case-Control Studies , Cholesterol/blood , Enzyme-Linked Immunosorbent Assay , Humans , Immunity , Myeloid Cells/immunology , Neutrophils/immunology , SARS-CoV-2/isolation & purification
8.
Mil Med Res ; 7(1): 16, 2020 04 04.
Article in English | MEDLINE | ID: covidwho-31674

ABSTRACT

In this Commentary, we would like to comment on the article titled "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)" as a featured article in Military Medical Research. In the guideline, except for "confirmed cases", "suspected cases", "close contact" and "suspicious exposure" were defined by clinical perspective based on epidemiological risk, clinical symptoms and auxiliary examination. Combined with our experience, we introduced a simple scoring proposal additionally based on not only CT imaging as strongly recommended by the guideline but also blood routine test, especially for primary screening of such patients in the out-patient department.


Subject(s)
Coronavirus Infections , Coronavirus , Pneumonia, Viral , Betacoronavirus , COVID-19 , Humans , Pandemics , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL